Dr Reddy's files marketing application for generic cholesterol-lowering drug

Dr Reddy's Laboratories has submitted a marketing application for the generic version of US-based pharmaceutical company Pfizer's cholesterol-lowering drug Lipitor in the US.

Pfizer said that in October 2009, Dr Reddy's Laboratories and Dr Reddy's Laboratories, Inc had notified the company that they had filed an abbreviated new drug application with the FDA seeking approval to market a generic version of Lipitor.

Under a settlement agreement with Pfizer, Ranbaxy has agreed to launch its generic by November 30, 2011. While the basic patent of Lipitor expires in the US in 2010, the related sub-patent expires in 2011.

 

Comments

Post a Comment

Popular posts from this blog

GOP Senator says it's hard to fund $14 billion children's health care program — then advocates for $1 trillion tax cut

Image
GOP Senator says it's hard to fund $14 billion children's health care program — then advocates for $1 trillion tax cut    Vox Author of GOP Tax Plan Says Children's Health Insurance Program Is Held Up “Because We Don't Have Money ...    The Intercept Nevada wins short reprieve in child health care funds fight    Sacramento Bee Ben McAdams: Congress to Tiny Tim: 'No health insurance for you.'    Salt Lake Tribune Full coverage
Read more

Trump wants more mental health care; Alabama says it's trying

Image
Trump wants more mental health care; Alabama says it's trying    AL.com Budget undercuts Trump focus on mental health, school safety    Yahoo News Mental health awareness license plates offered by New York State DMV    Buffalo News Trump wants to 'tackle the difficult issue of mental health?' He should put his money where his mouth is.    Washington Post Full coverage
Read more